Tissue microarray is inappropriate for analysis of BCL6 expression in diffuse large B-cell lymphoma

European Journal of Haematology

Volumn 79, Issue 2, 2007, Pages 146-149

  Linderoth, Johan ^a   Ehinger, Mats ^a   Åkerman, Måns ^a   Cavallin Ståhl, Eva ^a   Enblad, Gunilla ^b   Erlanson, Martin ^c   Jerkeman, Mats ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^c UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

BCL6; Diffuse large B cell lymphoma; Immunohistochemistry; Tissue microarray

Indexed keywords

ANTHRACYCLINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; INTERFERON REGULATORY FACTOR 6; PROTEIN BCL 6;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; FALSE NEGATIVE RESULT; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE MICROARRAY; TISSUE SECTION;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; NEPRILYSIN; PROTO-ONCOGENE PROTEINS C-BCL-6; TISSUE ARRAY ANALYSIS;

EID: 34447344536     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2007.00892.x     Document Type: Article

References (11)

1. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000 403 : 503 11.
2. Rosenwald A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002 346 : 37 47.
3. Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004 103 : 275 82.
4. Barrans SL, Carter I, Owen RG, Davies FE, Patmore RD, Haynes AP, Morgan GJ, Jack AS. Germinal center phenotype and bcl-2 expression combined with the International Prognostic Index improves patient risk stratification in diffuse large B-cell lymphoma. Blood 2002 99 : 1136 43.
5. Chang CC, McClintock S, Cleveland RP, Trzpuc T, Vesole DH, Logan B, Kajdacsy-Balla A, Perkins SL. Immunohistochemical expression patterns of germinal center and activation B-cell markers correlate with prognosis in diffuse large B-cell lymphoma. Am J Surg Pathol 2004 28 : 464 70.
6. Colomo L, Lopez-Guillermo A, Perales M, Rives S, Martinez A, Bosch F, Colomer D, Falini B, Montserrat E, Campo E. Clinical impact of the differentiation profile assessed by immunophenotyping in patients with diffuse large B-cell lymphoma. Blood 2003 101 : 78 84.
7. Linderoth J, Jerkeman M, Cavallin-Ståhl E, Kvaloy S, Torlakovic E. Immunohistochemical expression of CD23 and CD40 may identify prognostically favorable subgroups of diffuse large B-cell lymphoma: a Nordic Lymphoma Group Study. Clin Cancer Res 2003 9 : 722 8.
8. Hirose Y, Masaki Y, Karasawa H, Shimoyama K, Fukushima T, Kawabata H, Ogawa N, Wano Y, Ozaki M. Incidence of diffuse large B-cell lymphoma of germinal center B-cell origin in whole diffuse large B-cell lymphoma: tissue fluorescence in situ hybridization using t(14;18) compared with immunohistochemistry. Int J Hematol 2005 81 : 48 57.
9. de Jong D, Rosenwald A, Chhanabhai M, et al. Immunohistochemical prognostic markers in diffuse large B-cell lymphoma: validation of tissue microarray as a prerequisite for broad clinical applications-a study from the Lunenburg Lymphoma Biomarker Consortium. J Clin Oncol 2007 25 : 805 12.
10. Hedvat CV, Hegde A, Chaganti RS, Chen B, Qin J, Filippa DA, Nimer SD, Teruya-Feldstein J. Application of tissue microarray technology to the study of non- Hodgkin's and Hodgkin's lymphoma. Hum Pathol 2002 33 : 968 74.
11. Zettl A, Meister S, Katzenberger T, Kalla J, Ott MM, Muller-Hermelink HK, Ott G. Immunohistochemical analysis of B-cell lymphoma using tissue microarrays identifies particular phenotypic profiles of B-cell lymphomas. Histopathology 2003 43 : 209 19.